Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Merck & Co Inc V.MRK


Primary Symbol: MRK

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.


NYSE:MRK - Post by User

Comment by liverlesson Nov 14, 2009 2:13pm
436 Views
Post# 16487268

RE: Look out below !!!!

RE: Look out below !!!!I don't see anything unusual with the way they reported the drill results.  Why would they report the average grade for each hole?  This isn't a bulk tonnage open-pit style deposit.  

No doubt the widths weren't as good as the main zone, but they are still not bad.  The important thing for merc is to prove up more tonnage.  They did continue to do this with these results and they proved the mineralization is more dispersed then just a single zone.

So its hard for me to believe that these drill results are responsible for the selling.  As I said, they weren't unbelievable but they did hit on multiple intersections of very economic grades in a brand new zone 150m from the original zone.  Selling off a $9M market cap company because of results like that doesn't really make a lot of sense to me.

Knowing that there was a newletter writer putting out a sell recommendation explains a lot.  There is truth to the comments about flow-through shares.  They can weigh on a stock.  And maybe that is the truth behind the selling over the last couple months.  There's just too much paper out there.  I'd buy that.  Seeing flow through shares does put up a warning flag.  Why did they choose flow-through?  Were they forced to?  They also had 40cent units with half warrants but didn't seem to raise any money with it. 

If 25cents doesn't hold I think I would be willing to pick up more in the low 20s. 
<< Previous
Bullboard Posts
Next >>